Neuroprotective Effect of Humic Acid on Focal Cerebral Ischemia Injury: an Experimental Study in Rats

Inflammation

Volumn 38, Issue 1, 2015, Pages 32-39

  Ozkan, Adile ^a   Sen, Halil Murat ^a   Sehitoglu, Ibrahim ^b   Alacam, Hasan ^c   Guven, Mustafa ^a   Aras, Adem Bozkurt ^a   Akman, Tarik ^a   Silan, Coşkun ^a   Cosar, Murat ^a   Karaman, Handan Isin Ozisik ^a  

^a ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^b RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

^c ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

cerebrum; humic acid; ischemia

Indexed keywords

AUTACOID; CASPASE 3; CASPASE 9; DRUG THERAPY; HUMIC ACID; HUMIC SUBSTANCE; MALONALDEHYDE; NEUROPROTECTIVE AGENT; NUCLEAR RESPIRATORY FACTOR 1; PHARMACOLOGY; SUPEROXIDE DISMUTASE;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTAGONISTS AND INHIBITORS; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN DEGENERATION; BRAIN EDEMA; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECTS; ENZYME BLOOD LEVEL; HEMISPHERE; HISTOPATHOLOGY; HUMIC SUBSTANCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; METABOLISM; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; PREVENTION; PROTEIN BLOOD LEVEL; RAT; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; ANTAGONISTS AND INHIBITORS; BRAIN ISCHEMIA; DRUG EFFECTS; HUMIC SUBSTANCES; INFLAMMATION MEDIATORS; MALE; METABOLISM; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PATHOLOGY; PHARMACOLOGY; PHYSIOLOGY; PREVENTION AND CONTROL; RATS; RATS, SPRAGUE-DAWLEY; THERAPEUTIC USE; TREATMENT OUTCOME;

RATTUS;

EID: 85027945954     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-0005-0     Document Type: Article

References (42)

1. Brouns, R., and P.P. De Deyn. 2009. The complexity of neurological processes in acute ischemic stroke. Clinical Neurology and Neurosurgery 111: 483–495.
2. Lipton, P. 1999. Ischemic cell death in brain neurons. Physiological Reviews 79: 1431–1568.
3. Kuroda, S., and B.K. Siesjo. 1997. Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows. Clinical Neuroscience 4: 199–212.
4. Chan, P.H. 2001. Reactive oxygen radicals in signaling and damage in the ischemic brain. Journal of Cerebral Blood Flow and Metabolism 21: 2–14.
5. Zimmermann, C., K. Winnefeld, S. Streck, M. Roskos, R.L. Haberl, et al. 2004. Antioxidant status in acute stroke patients and patients at stroke risk. European Neurology 51: 157–61.
6. Simonyi, A., Q. Wang, R.L. Miller, et al. 2005. Polyphenols in cerebral ischemia: novel targets for neuroprotection. Molecular Neurobiology 31(1–3): 135–47.
7. Gilgun-Sherki, Y., E. Melamed, and D. Offen. 2001. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40: 959–975.
8. Cho, J.Y., I.S. Kim, Y.H. Jang, et al. 2006. Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia. Neuroscience Letters 404: 330–335.
9. Hartenstein, R. 1981. Sludge decomposition and stabilization. Science 212(802): 743–749.
10. Chen, Y., J. Katan, A. Gamliel, et al. 2000. Involvement of soluble organic matter in increased plant growth in solarized soils. Biology and Fertility of Soils 32: 28–34.
11. -Gostishcheva M.V.2008. Chemical-pharmaceutical study of native humic acids from peats of Tomsk Oblast, Cand. Sci. Dissertation, Perm
12. Van Rensburg, C.E.J., A. Van Straten, and J. Dekker. 2000. An in vitro investigation of the antimicrobial activity of oxifulvic acid. Journal of Antimicrobial Chemotherapy 46: 853–854.
13. Van Rensburg, C.E.J., S.C.K. Malfield, and J. Dekker. 2001. Topical application of oxifulvic acid suppresses the cutaneous immune response in mice. Drug Development Research 53: 29–32.
14. Cloete T. E, Swart H, Cronje I. J et al.1990. Oxidized coal products as industrial bactericides. Third International Symposium on Gas, Oil, Coal and Environmental Biotechnology, New Orleans, Louisiana, 3–5 December.
15. Van Rensburg, C.E.J., J. Dekker, R. Weis, et al. 2002. Investigation on the anti-HIV properties of oxihumate. Chemotherapy 48: 138–143.
16. Thiel, K.D., B. Helbig, R. Klöcking, et al. 1981. Comparison of the in vitro activities of ammonium humate and of enzymically oxidized chlorogenic and caffeic acids against type 1 and type 2 human herpes virus (author’s transl). Pharmazie 36(1): 50–3. German.
17. Vucskits, A.V., I. Hullár, A. Bersényi, et al. 2010. Effect of fulvic and humic acids on performance, immune response and thyroid function in rats. Journal of Animal Physiology and Animal Nutrition (Berlin) 94(6): 721–8.
18. Efimova, I.V., S.L. Khil’ko, and O.V. Smirnova. 2012. Antioxidant activity of humic acids in radical-chain oxidation processes. Russian Journal of Applied Chemistry 85(9): 1351–54.
19. Longa, E.Z., P.R. Weinstein, S. Carlson, et al. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20(1): 84–91.
20. Lowry, O.H., N.J. Rosebrough, A.L. Farr, et al. 1951. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 265–75.
21. Sun, Y., L.W. Oberley, and Y. Li. 1988. A simple method for clinical assay of superoxide dismutase. Clinical Chemistry 34: 497–500.
22. Durak, I., Z. Yurtarslanl, O. Canbolat, et al. 1993. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clinica Chimica Acta 214: 103–4.
23. Buege, J.A., and S.D. Aust. 1978. Microsomal lipid peroxidation. Methods in Enzymology 52: 302–10.
24. Park, H.S., K.H. Han, J.A. Shin, et al. 2014. The neuroprotective effects of carnosine in early stage of focal ischemia rodent model. Journal of Korean Neurosurgical Society 55(3): 125–30.
25. Bonita, R., S. Mendis, T. Truelsen, et al. 2004. The global stroke initiative. Lancet Neurology 3: 391–393.
26. Evans, P.H. 1993. Free radicals in brain metabolism and pathology. British Medical Bulletin 49: 577–587.
27. Durukan, A., and T. Tatlisumak. 2007. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacology Biochemistry and Behavior 87: 179–197.
28. Braughler, J.M., and E.D. Hall. 1989. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radical Biology and Medicine 6: 289–301.
29. Bromont, C., C. Marie, and J. Bralet. 1989. Increased lipid peroxidation in vulnerable brain regions after transient forebrain ischemia in rats. Stroke 20(7): 918–24.
30. Zhang, Q., Y. Wu, P. Zhang, et al. 2012. Exercise induces mitochondrial biogenesis after brain ischemia in rats. Neuroscience 15(205): 10–7.
31. St-Pierre, J., S. Drori, M. Uldry, et al. 2006. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127(2): 397–408.
32. EMEA. Humic acids and their sodium salts, summary report. Committee for Veterinary Medicinal Products. European Agency for the Evaluation of Medicinal Products Available via http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-Report/2009/11/WC500014416.pdf; 1999
33. Brzozowski, T., A. Dembiński, and S. Konturek. 1994. Influence of Tołpa Peat Preparation on gastroprotection and on gastric and duodenal ulcers. Acta Poloniae Pharmaceutica 51(1): 103–7.
34. Riede, U.N., I. Jonas, B. Kirn, et al. 1992. Collagen stabilization induced by natural humic substances. Archives of Orthopaedic and Trauma Surgery 111(5): 259–64.
35. Hu, C.W., C.C. Yen, Y.L. Huang, et al. 2010. Oxidatively damaged DNA induced by humic acid and arsenic in maternal and neonatal mice. Chemosphere 79(1): 93–9.
36. Hseu, Y.C., S.C. Chen, Y.L. Chen, et al. 2008. Humic acid induced genotoxicity in human peripheral blood lymphocytes using comet and sister chromatid exchange assay. Journal of Hazardous Materials 153: 784–791.
37. Gau, R.J., H.L. Yang, J.L. Suen, et al. 2001. Induction of oxidative stress by humic acid through increasing intracellular iron: a possible mechanism leading to atherothrombotic vascular disorder in blackfoot disease. Biochemical and Biophysical Research Communications 283: 743–749.
38. Cheng, M.L., H.Y. Ho, Y.W. Huang, et al. 2003. Humic acid induces oxidative DNA damage, growth retardation, and apoptosis in human primary fibroblasts. Experimental Biology and Medicine (Maywood, N.J.) 228(4): 413–23.
39. Cheng, M.L., H.Y. Ho, D.T. Chiu, et al. 1999. Humic acid-mediated oxidative damages to human erythrocytes: a possible mechanism leading to anemia in blackfoot disease. Free Radical Biology and Medicine 27(3–4): 470–477.
40. Kodama, H., and Denso. 2007. Antitumor effect of humus extract on murine transplantable L1210 leukemia. Journal of Veterinary Sciences and Medicine 69: 1069–1071.
41. Kodama, H., Okazaki F. Denso, and S. Ishida. 2008. Protective effect of humus extract against Trypanosoma brucei infection in mice. Journal of Veterinary Medical Science 70(11): 1185–90.
42. Joone, G.K., J. Dekker, and C.E. Van Rensburg. 2003. Investigation of the immunostimulatory properties of oxihumate. Zeitschrift fu¨ r Naturforschung. C 58: 263–267.